Repurposing abiraterone for the treatment of AR+ salivary gland carcinomas
Alfredo Berruti • 21 Mar 2023
The rationale behind exploring adjuvant therapy in low-intermediate risk adrenocortical carcinoma
Alfredo Berruti • 17 Feb 2022
Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Keep up to date with all the latest news with our monthly newsletter